
Episodes

Wednesday Jul 29, 2020
An Overview of Prostate Cancer
Wednesday Jul 29, 2020
Wednesday Jul 29, 2020
Prostate cancer is the most common cancer among men and predominately affects elderly men with a higher incidence. Deregulated production and secretion of growth factors by stromal cells within the PCa microenvironment, as well as mutations in androgen signaling pathway components and further physiological modifications, potentially lead to systemic recurrence of prostate cancer, including the appearance of focal tumor in advanced stage. Optimizing early diagnosis and developing targeted therapy of pancreatic cancer are the key to improving the survival rate of patients. In the episode, we will give you a comprehensive introduction to prostate cancer and its signaling pathways, diagnostic markers, and targeted therapies, as well as Creative Biolabs' antibody-related products and services to help fully understand how important it is to optimize early diagnosis and develop targeted drugs.
Comments (0)
To leave or reply to comments, please download free Podbean or
No Comments
To leave or reply to comments,
please download free Podbean App.